eMedicine Specialties > Radiology > Brain/Spine

Schwannoma, Cranial Nerve: Imaging

Author: Mahesh Jayaraman, MD, Interventional Neuroradiology Fellow, Department of Radiology, Stanford University Medical Center
Coauthor(s): Lawrence M Davis, MD, Assistant Professor of Diagnostic Imaging (Clinical), Department of Diagnostic Imaging, Brown Medical School
Contributor Information and Disclosures

Updated: Oct 18, 2007

Radiography

Findings

No role exists for plain radiographic evaluation of schwannomas. Findings on conventional radiographs are nonspecific, and typically, lesions are visualized on plain radiographs only when they are large.

Computed Tomography

Findings

On nonenhanced CT scans, most schwannomas are isoattenuating relative to brain parenchyma. Calcification or areas of hemorrhage are rare. On contrast-enhanced CT scans, the enhancement pattern is typically homogeneous.2

Bone-window images can demonstrate remodeling of the adjacent skull base, such as expansion of the IAC by vestibular schwannomas and expansion of the facial canal by facial schwannomas (see Image 7). Expansion of the jugular foramen by CN IX, CN X, or CN XI schwannomas can also be seen.

Thin-collimation CT imaging of the skull base can be helpful in evaluating bone destruction. This finding is useful in differentiating jugular foramen schwannomas from paragangliomas (see Image 23).

Degree of Confidence

With CT, large lesions can be diagnosed with a high degree of confidence. Distinguishing a schwannoma from a meningioma may not be possible by using CT. A small lesion that affects a CN cannot be confidently excluded.

False Positives/Negatives

CT findings can be false-negative in small lesions. Occasionally, a false-positive diagnosis occurs because a streak artifact in the cerebellopontine angle cistern mimics a lesion.

Magnetic Resonance Imaging

Findings

Similar to CT imaging, MRI tends to depict schwannomas as homogeneous masses.1,7 Schwannomas are typically isointense or slightly hypointense relative to gray matter on T1-weighted images and slightly hypointense to CSF on T2-weighted images. Gadolinium enhancement is typically homogeneous, although larger schwannomas can show areas of cystic degeneration and heterogeneous signal intensity; these findings are based on increased numbers of areas with Antoni type B histologic features.

High-resolution thin-section heavily T2-weighted 3-dimensional sequences have been used to look for acoustic neuromas. On images obtained with these sequences, individual nerves in the cistern and IAC can be visualized as linear filling defects in the bright CSF. Small masses can be identified without the use of an intravenously administered contrast agent (see Image 3).

Vestibular schwannomas are the most common CN schwannomas. Typically, the masses are located in the cerebellopontine angle (CPA) and centered at the porus, with extension into the IAC. Their appearance has been described as that of a comet tail or ice cream cone, with the cone as the intracanalicular extension and the ice cream as the cisternal component. The long axis of the tumors is parallel to the petrous surface.

Occasionally, tumors can be entirely intra-canicular, in which case the primary differential diagnosis is a meningioma of the CPA. Unlike vestibular schwannomas, meningiomas tend to form obtuse angles with the adjacent petrous bone, are typically hemispheric, and often extend into the middle fossa as a result of herniation (see Images 1-5). Meningiomas can be differentiated by their broad base of attachment along the petrous bone and by the presence of a dural tail. Meningiomas uncommonly extend into the internal auditory canal.7

Schwannomas of the facial nerve can occur along any segment, but they frequently involve the geniculate ganglion and extend proximally or distally from there. MRI and CT imaging characteristics are similar to those of vestibular schwannomas. The location of the mass results in variable growth patterns. In the IAC, facial schwannomas are indistinguishable from vestibular lesions. When facial schwannomas cross the petrous bone to involve both the middle and posterior fossa, they cross in the mid portion of the petrous bone. In contrast, trigeminal schwannomas cross near the petrous apex. Lesions in the geniculate ganglion can be mistaken for temporal lobe lesions, and imaging in the coronal plane is useful in evaluating the lesions (see Images 8-9).

Trigeminal schwannomas can arise in the Meckel cave or in the cistern along the course of the nerve.8 Extension and expansion of the foramen rotundum or ovale is common, and the masses can have a bilobed appearance. Tumors can also grow posteriorly to involve the posterior fossa, or they can grow anteriorly into the cavernous sinus. Trigeminal schwannomas tend to have a more cystic component than other schwannomas (see Images 12-15).

Glossopharyngeal, vagus, or accessory nerve schwannomas are rare and difficult to distinguish from one another. The tumors are classified on the basis of their growth patterns: Type A lesions grow predominantly intracranially, type B lesions grow predominantly at the jugular foramen, and type C lesions grow predominantly extracranially. CT and MRI characteristics are similar to those of other schwannomas. In contrast to the more common paragangliomas in this region, schwannomas expand but do not infiltrate the adjacent bone (see Images 19-20). Unlike paragangliomas, which infiltrate and erode adjacent bone, schwannomas smoothly expand the bone and leave an intact cortical margin.

Hypoglossal schwannomas have growth patterns and imaging characteristics similar to those of jugular foramen schwannomas. When large enough, the tumors can erode the hypoglossal canal to such an extent that their differentiation from jugular foramen schwannomas can be difficult.6

Schwannomas of abducens nerve (ie, CN VI) are rare. They are reported to occur in the prepontine cistern, with a heterogeneous appearance on CT scans and MRIs and extension into the adjacent cavernous sinus. As with other schwannomas, meningioma is the primary differential diagnosis, and the presence of areas of cystic change (which have high signal intensity on T2-weighted images) can suggest the likelihood of schwannoma instead of meningioma. Similarly, CN IV schwannomas are rare (see Image 17).

Schwannomas of the oculomotor nerve are reported in the literature, but they are exceedingly rare. The tumors can present as masses in the suprasellar cistern, and they can be difficult to distinguish from meningiomas in this region.

Gadolinium-based contrast agents (gadopentetate dimeglumine [Magnevist], gadobenate dimeglumine [MultiHance], gadodiamide [Omniscan], gadoversetamide [OptiMARK], gadoteridol [ProHance]) have recently been linked to the development of nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD). For more information, see the eMedicine topic Nephrogenic Fibrosing Dermopathy. The disease has occurred in patients with moderate to end-stage renal disease after being given a gadolinium-based contrast agent to enhance MRI or MRA scans. As of late December 2006, the FDA had received reports of 90 such cases. Worldwide, over 200 cases have been reported, according to the FDA. NSF/NFD is a debilitating and sometimes fatal disease. Characteristics include red or dark patches on the skin; burning, itching, swelling, hardening, and tightening of the skin; yellow spots on the whites of the eyes; joint  stiffness with trouble  moving  or  straightening  the  arms,  hands,  legs,  or  feet;  pain deep in the hip bones or ribs; and muscle weakness. For more information, see the FDA Public Health Advisory or Medscape.

Degree of Confidence

A diagnosis of a CN mass can be made with a high degree of confidence by using MRI.

False Positives/Negatives

False-positive findings occur primarily in the jugular fossa, where slow flow in the jugular bulb can mimic a mass. A false-negative diagnosis can occur if imaging is inadequate — for example, if the image sections are too thick or if fat suppression is not used in evaluating the skull base.

Ultrasonography

Findings

No role exists for ultrasonography in the evaluation of CNs.

Nuclear Imaging

Findings

No role exists for nuclear medicine studies in the evaluation of CNs.

Angiography

Findings

Angiography is not used as a diagnostic modality for schwannomas. When studied with angiography, schwannomas typically appear hypovascular; this finding distinguishes them from paragangliomas when the lesion is in the jugular fossa (see Image 24).

More on Schwannoma, Cranial Nerve

Overview: Schwannoma, Cranial Nerve
Imaging: Schwannoma, Cranial Nerve
Follow-up: Schwannoma, Cranial Nerve
Multimedia: Schwannoma, Cranial Nerve
References

References

  1. Atlas S, ed. Magnetic Resonance Imaging of the Brain and Spine. 2nd ed. Lippincott-Raven;1996:781-6.

  2. Chung SY, Kim DI, Lee BH, et al. Facial nerve schwannomas: CT and MR findings. Yonsei Med J. Apr 1998;39(2):148-53. [Medline].

  3. Shah N, Sibtain A, Saunders MI, et al. High FDG uptake in a schwannoma: a PET study. J Comput Assist Tomogr. Jan-Feb 2000;24(1):55-6. [Medline].

  4. Yuh WT, Wright DC, Barloon TJ, et al. MR imaging of primary tumors of trigeminal nerve and Meckel''s cave. AJR Am J Roentgenol. Sep 1988;151(3):577-82. [Medline].

  5. Wilson-Pauwels L, Akesson EJ, Stewart PA. Cranial Nerves: Anatomy and Clinical Comments. Decker BC;1998.

  6. Gomez Beldarrain M, Fernandez Canton G, Garcia-Monco JC. Hypoglossal schwannoma: an uncommon cause of twelfth-nerve palsy. Neurologia. Apr 2000;15(4):182-3. [Medline].

  7. Schmalbrock P, Chakeres DW, Monroe JW, et al. Assessment of internal auditory canal tumors: a comparison of contrast- enhanced T1-weighted and steady-state T2-weighted gradient-echo MR imaging. AJNR Am J Neuroradiol. Aug 1999;20(7):1207-13. [Medline].

  8. Colreavy MP, Lacy PD, Hughes J, et al. Head and neck schwannomas--a 10 year review. J Laryngol Otol. Feb 2000;114(2):119-24. [Medline].

  9. Bennett M, Haynes DS. Surgical approaches and complications in the removal of vestibular schwannomas. Otolaryngol Clin North Am. Jun 2007;40(3):589-609, ix-x. [Medline].

  10. Backous DD, Pham HT. Guiding patients through the choices for treating vestibular schwannomas: balancing options and ensuring informed consent. Otolaryngol Clin North Am. Jun 2007;40(3):521-40, viii-ix. [Medline].

  11. Kabil MS, Shahinian HK. A series of 112 fully endoscopic resections of vestibular schwannomas. Minim Invasive Neurosurg. Dec 2006;49(6):362-8. [Medline].

  12. Eldevik OP, Gabrielsen TO, Jacobsen EA. Imaging findings in schwannomas of the jugular foramen. AJNR Am J Neuroradiol. Jun-Jul 2000;21(6):1139-44. [Medline].

  13. Gilmer-Hill HS, Kline DG. Neurogenic tumors of the cervical vagus nerve: report of four cases and review of the literature. Neurosurgery. Jun 2000;46(6):1498-503. [Medline].

  14. Ginsberg F, Peyster RG, Rose WS, Drapkin AJ. Sixth nerve schwannoma: MR and CT demonstration. J Comput Assist Tomogr. May-Jun 1988;12(3):482-4. [Medline].

  15. Katsumata Y, Maehara T, Noda M, Shirouzu I. Neurinoma of the oculomotor nerve: CT and MR features. J Comput Assist Tomogr. Jul-Aug 1990;14(4):658-61. [Medline].

  16. Mackle T, Rawluk D, Walsh RM. Atypical clinical presentations of vestibular schwannomas. Otol Neurotol. Jun 2007;28(4):526-8. [Medline].

  17. Weissman JL. Hearing loss. Radiology. Jun 1996;199(3):593-611. [Medline].

Further Reading

Keywords

neuroma; CN schwannomas; Schwann cells; vestibular schwannomas; trigeminal schwannomas; facial schwannomas; glossopharyngeal schwannomas; vagus schwannomas; spinal accessory schwannomas; oculomotor schwannomas; hypoglossal schwannomas; abducens schwannomas; trochlear schwannomas; neurofibromatosis type 2; NF2; multiple inherited schwannomas, meningiomas, and ependymomas syndrome; MISME syndrome

Contributor Information and Disclosures

Author

Mahesh Jayaraman, MD, Interventional Neuroradiology Fellow, Department of Radiology, Stanford University Medical Center
Mahesh Jayaraman, MD is a member of the following medical societies: Radiological Society of North America
Disclosure: Nothing to disclose.

Coauthor(s)

Lawrence M Davis, MD, Assistant Professor of Diagnostic Imaging (Clinical), Department of Diagnostic Imaging, Brown Medical School
Lawrence M Davis, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, American Society of Neuroradiology, Radiological Society of North America, and Rhode Island Medical Society
Disclosure: Nothing to disclose.

Medical Editor

Mahesh R Patel, MD, Chief of MRI, Department of Radiology, Santa Clara Valley Medical Center
Mahesh R Patel, MD is a member of the following medical societies: Radiological Society of North America
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

James G Smirniotopoulos, MD, Professor of Radiology, Neurology, and Biomedical Informatics, Chairman, Department of Radiology and Radiological Sciences, Uniformed Services University of the Health Sciences
James G Smirniotopoulos, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, American Society of Head and Neck Radiology, American Society of Neuroradiology, American Society of Pediatric Neuroradiology, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.